FROM 03/02/2018 | Other 98%
BY Alexander Zaitchik
A sweeping study of drug R&D funding shows the public pays for the crucial foundations of medical breakthroughs. So why not let the public have access to them? Something odd happened when the Trump administration submitted the original version of its latest pro-corporate budget: Big Pharma didn’t like it. The problem wasn’t a tax hike […]
see source